PT  - JOURNAL ARTICLE
AU  - Odo Diekmann
AU  - Hans G. Othmer
AU  - Robert Planqué
AU  - Martin C. J. Bootsma
TI  - On discrete time epidemic models in Kermack-McKendrick form
AID  - 10.1101/2021.03.26.21254385
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.26.21254385
4099  - http://medrxiv.org/content/early/2021/03/26/2021.03.26.21254385.short
4100  - http://medrxiv.org/content/early/2021/03/26/2021.03.26.21254385.full
AB  - Surprisingly, the discrete-time version of the general 1927 Kermack-McKendrick epidemic model has, to our knowledge, not been formulated in the literature, and we rectify this omission here. The discrete time version is as general and flexible as its continuous-time counterpart, and contains numerous compartmental models as special cases. In contrast to the continuous time version, the discrete time version of the model is very easy to implement computationally, and thus promises to become a powerful tool for exploring control scenarios for specific infectious diseases. To demonstrate the potential, we investigate numerically how the incidence-peak size depends on model ingredients. We find that, with the same reproduction number and initial speed of epidemic spread, compartmental models systematically predict lower peak sizes than models that use a fixed duration for the latent and infectious periods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Dutch NWO.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/a